YHLO

2023-03-17

Summary:





New office, new starting point!

Congratulations! On 15th Mar. 2023, YHLO R&D Center Japan officially settled in Tachikawa, Tokyo! This is not only a new office but also a new starting point for YHLO R&D Center Japan.

YHLO R&D Center Japan was officially established in Tokyo on March 18, 2022. It is mainly devoted to the new technology of IVD devices, which is a significant part of YHLO's global strategy.

Previous: Nobel Prize Winner Professor Arieh Warshe visited YHLO

Next: One more YHLO international regional office!

Home

About YHLO

Products

Services

News

Company Profile Milestone Corporate Values

About YHLO

YHLO (EST. 2008) is an innovative and steadfastly growing company of immunoassay solutions headquartered in Shenzhen, China, specialized in developing, manufacturing and distributing in-vitro diagnostic instruments and reagents by a team of experienced scientists and engineers. In May of 2021, YHLO has successfully launched IPO and listed on Shanghai Stock Exchange (Stock code: 688575).

More +

Clinical Solution CLIA ELISA LIA ESR COVID-19

Products

Based on the technology platforms of CLIA, ELISA, LIA and immunofluorescence, YHLO is specialized in diagnosis of autoimmunity, reproductive health, diabetes, infectious diseases etc.

More +